ArticleScientific reports2015
The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer's disease amyloid-β peptides.
Xiling Lei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this papercites it